Trial intelligence / Profile preview

TETRAXIM primary vaccination in healthy South Korean infants

2015-005348-33Phase 3

Sponsor
Sanofi
Start
Dec 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of diphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccine, diphtheria, tetanus, and acellular pertussis vaccine, inactivated poliovirus vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Sanofi.

02

Drugs

diphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccinediphtheria, tetanus, and acellular pertussis vaccineinactivated poliovirus vaccine
03

Conditions

diphtheriaTetanuspertussispoliomyelitis

Beyond the preview

Go deeper on 2015-005348-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005348-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call